Blood type transfusion can be considered safe as long as the serum of the recipient does not contain antibodies for the blood cell antigens of the donor. The "ABO system" is the most important blood-group system in human-blood transfusion. The associated anti-A and anti-B antibodies are usually "immunoglobulin M", abbreviated IgM, antibodies. ABO IgM antibodies are produced in the first years of life by sensitization to environmental substances such as food, bacteria, and viruses. The original terminology used by Karl Landsteiner in 1901 for the classification was A/B/C; in later publications "C" became "O". Type O is often called "0" ("zero", or
ABO blood group system plant antigens) have epitopes similar enough to A and B glycoprotein antigens. The antibodies created against these environmental antigens in the first years of life can cross-react with ABO-incompatible red blood cells that it comes in contact with during blood transfusion later in life. Anti-A antibodies are hypothesized to originate from immune response towards influenza virus, whose epitopes are similar enough to the α-D-N-galactosamine on the A glycoprotein to be able to elicit a cross-reaction. Anti-B antibodies are hypothesized to originate from antibodies produced against Gram-negative bacteria, such as "E. coli", cross-reacting with the α-D-galactose on the B glycoprotein. However,